FIELD: biotechnology.
SUBSTANCE: invention refers to compositions and methods of treating cerebral cancer having mutations in a retinoblastoma (Rb) metabolic pathway, using oncolytic adenovirus containing a change in the Rb binding E1A region and isolating a motif inserted into the fibrillar protein Ad.
EFFECT: adenovirus is capable of destroying tumour cells without damaging cells of the metabolic pathway of wild type retinoblastoma.
30 cl, 10 dwg, 2 tbl, 2 ex
Title |
Year |
Author |
Number |
THERAPEUTIC COMPOSITIONS AND METHODS OF USING FOR TREATING CANCER |
2016 |
- Shaw, Steven
- Westby, Michael
- Galili, Uri
|
RU2720984C2 |
ONCOLYTIC ADENOVIRUSES ENCODING BISPECIFIC ANTIBODIES, AS WELL AS METHODS AND APPLICATIONS ASSOCIATED THEREWITH |
2016 |
- Siurala, Mikko
- Liikanen, Ilkka
- Tahtinen, Siri
- Parviainen, Suvi
- Hemminki, Akseli
|
RU2725799C2 |
EXTENDED ADOPTIVE CELL THERAPY |
2014 |
- Khemminki, Akseli
- Vyakhya-Koskela, Markus
- Tyakhtinen, Siri
- Cherullo, Vinchentso
|
RU2703438C2 |
ADENOVIRAL VECTORS AND RELATED METHODS AND APPLICATIONS |
2009 |
- Khemminki Akseli
- Kanerva Anna
- Cherullo Vinchentso
- Pesonen Sari
|
RU2520823C2 |
ONCOLYTIC ADENOVIRUS FOR TREATING CANCER, USING IT, AND PHARMACEUTICAL COMPOSITION CONTAINING IT |
2010 |
- Gedan Karrio Sonija
- Kaskal'O Pikeras Manel' Marija
- Alemani Bonastre Ramon
|
RU2536931C2 |
ADENOVIRUS CONTAINING ALBUMIN-BINDING SITE |
2015 |
- Alemany Bonastre, Ramon
- Rojas Exposito, Luis Alfonso
|
RU2711371C2 |
METHOD AND COMPOSITION FOR DIAGNOSING AND TREATING CANCER |
1996 |
|
RU2174409C2 |
TREATMENT OF TUMORS WITH A COMBINATION OF ONCOLYTIC ADENOVIRUS AND CDK4/6 INHIBITOR |
2019 |
- Holm, Per, Sonne
- Nawroth, Roman
|
RU2811278C2 |
DESIGNING OF CARCINOLYTIC ADENOVIRUS RECOMBINANT, SPECIFICALLY EXPRESSING IMMUNOMODULATORY FACTOR GM-CSF IN TUMORAL CELLS AND ITS APPLICATION |
2004 |
|
RU2361611C2 |
COATED ONCOLYTIC ADENOVIRUS FOR ANTICANCER VACCINES |
2015 |
- Cherullo Vinchentso
- Vyakhya-Koskela Markus
- Khirvinen Mari
- Kapasso Kristian
|
RU2695375C2 |